Online Inquiry
Iniparib (BSI-201)
SPC-01096
CAS No. 160003-66-7
| Size | Price |
| 10 mM (1 mL in DMSO) | Online Inquiry |
| 10 mg | Online Inquiry |
| 50 mg | Online Inquiry |
| 200 mg | Online Inquiry |
| Bulk Size | Online Inquiry |
PARP inhibitor
| Description |
|---|
| Iniparib (BSI-201, NSC-746045, IND-71677) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3. |
| Product Details | |
|---|---|
| CAS No. | CAS No. 160003-66-7 |
| Description | Iniparib (BSI-201, NSC-746045, IND-71677) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3. |
| Formula | C7H5IN2O3 |
| Molecular Weight | 292.03 |
| Storage | 3 years -20°C powder 2 years -80°C in solvent |
| Synonyms | NSC-746045, IND-71677 |
| SMILES | C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I |
| Solubility | DMSO |
| Usage | |
|---|---|
| Storage | 3 years -20°C powder 2 years -80°C in solvent |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.